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Abstract
Glucose transporter 4 (GLUT-4) plays a key role in the pathophysiology of type 2 
diabetes. GLUT-4 is upregulated in response to exercise, enhancing cellular glucose transport in 
skeletal muscle tissue. This mechanism appears to remain intact in individuals with insulin 
resistance. There is evidence of increased translocation of GLUT-4 and increased transcription of 
SLC2A, the gene which codes for GLUT-4. Details of the mechanism are poorly understood and 
are challenging to study due to the invasive nature of muscle biopsy. Peripheral blood 
mononuclear cells (PBMC) have documented insulin-sensitive GLUT-4 activity and may serve 
as a proxy tissue for studying skeletal muscle GLUT-4. The purpose of this study was to 
investigate whether GLUT-4 on PBMC is affected by exercise in a similar fashion to myocytes. 
Additionally, correlations between PBMC GLUT-4 and common indicators of insulin resistance 
and dietary patterns were examined. The results show a trend toward higher PBMC GLUT-4 
levels in conditioned athletes than in their sedentary counterparts, similar to what has been 
documented in myocytes. Females were shown to have higher PBMC GLUT-4 levels than 
males. SLC2A4 mRNA analysis demonstrates a difference in mean gene expression between the 
conditioned and sedentary participants. Correlations between levels of PBMC GLUT-4 and 
hemoglobin A1c (HbA1c), glucose, insulin, HOMA-IR, BMI, or body fat were not detected. 
Relationships between specific nutrients and GLUT-4 were also not detected. This study 
provides evidence to support exploration of PBMC as a proxy tissue for studying GLUT-4 
response to exercise or other non-insulin factors. This could provide important treatment avenues 
for individuals with insulin resistance and type 2 diabetes.
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1.1 Type 2 Diabetes and Insulin Resistance
Diabetes is a pervasive health problem in the United States affecting an estimated 29.1 
million people, a number which has tripled in the past three decades.1 One in three people will 
develop diabetes in their lifetime. The disease has estimated direct and indirect costs of a 
staggering $245 billion annually.1 Of those diagnosed, over 95% have Type 2 diabetes. The vast 
majority of these individuals with Type 2 diabetes are on antidiabetic medications.1 
Unfortunately, 8.1 million people who have the disease do not even know they have it.1
Central to the pathophysiology of diabetes is insulin resistance whereby the cells, 
particularly muscle and adipose cells, do not utilize insulin efficiently. This leads to elevated 
blood glucose levels, beginning the pathology of diabetes. Prediabetes is the condition where 
blood glucose is elevated above normal levels, but not yet to the threshold for the diagnosis of 
diabetes. Of the 86 million Americans with prediabetes, nine out of ten are undiagnosed and 15­
30% of these individuals will develop Type 2 diabetes within 5 years.1
Type 2 diabetes is a progressive disorder; one goal is early detection of metabolic 
aberrations signifying the beginning of the pathology. Early identification provides an 
opportunity for lifestyle changes that can slow progression, however effective clinical tools for 
that detection are lacking. Insulin resistance is one early indicator, but currently there is not an 
effective clinical diagnostic tool for insulin resistance prior to the individual developing 
prediabetes. When glucose levels reach the diagnostic criteria for prediabetes, it is assumed 
insulin resistance is present.
Chapter 1: Glucose Transporter 4 (GLUT-4) and Glucose Metabolism Disorders
1
Impaired glucose transporter 4 (GLUT-4) production and trafficking play a key role in 
the pathophysiology of type 2 diabetes and insulin resistance (IR). GLUT-4 has been a target for 
identification3,4 and treatment5 of glucose metabolism disorders. GLUT-4 resides in intracellular 
pools in membranes of small vesicles and is translocated to the cell membrane in response to 
insulin. Additionally, GLUT-4 has been shown to increase in skeletal muscle in humans and 
animals in response to exercise, independent of insulin.6-16 It is commonly believed the increase 
in GLUT-4 levels is due to increased translocation from an intracellular pool rather than
17increased transcription, however that has not been conclusively determined. Evidence supports 
the hypothesis that exercise stimulates a different mechanism and potentially draws from a 
different intracellular pool of GLUT-4.6 Although individuals with IR or type 2 diabetes have 
diminished GLUT-4 response to insulin, the response to exercise may be uninhibited.6,10,18 This 
is an important physiological consideration, as it provides a potential alternate pathway to 
improve blood glucose control in patients with IR.
8,12Chronic exercise elevates basal GLUT-4 levels. ’ A GLUT-4 increase is seen both in 
conditioned athletes and in individuals participating in shorter duration and less intense 
exercise.6,12,15 Minimal strength training has similarly resulted in an increase in GLUT-4 in 
muscle tissue.10 On the other hand, some studies have failed to show this increase in GLUT-4 in 
myocytes after short duration exercise.19,20 As a whole, the data suggest that a variety of type, 
intensity, and duration of physical activity stimulate GLUT-4 translocation in skeletal muscle, 
improving cellular glucose transport.
1.2 Glucose transporter 4 (GLUT-4): Cell Signaling, Trafficking, and Gene Regulation
2
The SLC2A4 gene codes for the GLUT-4 protein and multiple transcriptional regulators
21 24are involved in SLC2A4 expression. Exercise increases SLC2A4 transcriptional activity. ' 
Specific regulatory areas in the promoter region SLC2A4 have been analyzed for their response 
to exercise. The myocyte enhancer factor (MEF2) shows increased binding in response to
25-27exercise. ' Histone acetylation/deacetylation also appears to be involved in SLC2A4
27,28expression. ’ Overall, a better understanding of the impact of exercise on SLC2A4 expression, 
GLUT-4 production, and GLUT-4 translocation is needed when considering interventions for 
glucose metabolism disorders.
1.3 Challenges in Researching GLUT-4
GLUT-4 is predominantly found in muscle and adipose tissue. One barrier to studying 
GLUT-4 regulation is the need for a biopsy from these tissues. The invasive nature and expense 
of this procedure has resulted in limited human studies and small sample sizes. Peripheral blood 
mononuclear cells (PBMC) are shown to have insulin-sensitive GLUT-4 activity and could 
potentially serve as a proxy tissue. Monocytes, a sub-population of mononuclear cells, were
29,30originally identified as having the majority of the insulin binding sites ’ as well as GLUT-4
31activity within the mononuclear cell population; therefore, monocytes have been used in many 
insulin sensitivity studies. Lymphocytes have also demonstrated GLUT-4 activity in response to
3,5,32-34insulin. ’ ’ " The research to date on GLUT-4 activity in mononuclear cells suggests these cells 
respond to insulin similar to muscle tissue. What has not been explored is whether they also 
respond to exercise in a similar fashion. Our lab recently reported, for the first time, higher
35GLUT-4 on mononuclear cells of conditioned versus sedentary sled dogs, however similar 
findings have not been reported in humans.
3
Another challenge in diabetes prevention and treatment is the lack of early identification 
of those at risk. Early identification of individuals at risk for type 2 diabetes or IR may allow an 
exercise or lifestyle intervention to be implemented prior to disease progression. However, 
current routine diagnostic tools only detect physiological abnormalities once they result in 
inadequate glucose transport.4 Inexpensive, direct, reliable identification of early physiological 
changes that are likely to lead to type 2 diabetes would be beneficial for early intervention.
1.4 Study Purpose
The current study addressed the following research questions:
1) Do conditioned athletes have higher GLUT-4 levels in PBMC than sedentary 
individuals akin to the documented difference in skeletal muscle? Demonstrating an increase in 
PBMC GLUT-4 in conditioned individuals similar to that in myocytes would suggest that PBMC 
could provide a proxy tissue for studying GLUT-4 activity. The current study was designed as an 
initial exploration of this idea to determine whether more extensive studies are warranted.
2) Are there correlations between PBMC GLUT-4 and common indicators of insulin 
resistance? Correlations between PBMC GLUT-4 and common indicators of IR could lead to 
development of an early diagnostic tool for IR, promoting earlier interventions and prevention of 
disease progression.
3) Is there evidence for increased transcription of SLC2A4 in PBMC in conditioned 
athletes versus sedentary individuals? Although much emphasis is placed on GLUT-4 
translocation, SLC2A4 transcription could also be an important molecular mechanism and a 
target for treatment. Again, PBMC may serve as a viable cell type for studying such the impact 
of diet, exercise, or medications on SLC2A4 transcription.
4
4) Does dietary intake affect GLUT-4 or SLC2A4 mRNA levels? Because nutrient intake 
is known to stimulate insulin, and thereby GLUT-4, dietary data was analyzed to assess 
relationships between specific nutrients and food groups and GLUT-4 activity in PBMCs.
5
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Chapter 2: GLUT-4 Regulation in Response to Exercise and Diet
2.1 Glucose Transporter 4 (GLUT-4) Protein
The solute carrier family 2 facilitated glucose transporter member 4 (GLUT-4) is a 
member of a family of facilitative glucose transporters. GLUT-4 is 509 amino acids long, with 
twelve helical transmembrane domains.36 The protein is found in a variety of tissues, but most 
widely recognized in skeletal muscle and adipose tissue. GLUT-4 resides in storage vesicles 
(GSVs) within the cell, primarily in the perinuclear region.37 Cell stimulation causes the GSV to
38translocate to the plasma membrane, delivering GLUT-4. When cellular need for glucose 
diminishes, GLUT-4 is returned to the GSV. Insulin and exercise both have the capacity to
39trigger this process using distinct signaling pathways.
2.1.1 Stimulation of GLUT-4 Activity
Insulin is the most widely understood stimulator for GLUT-4 translocation. Insulin is 
released when there is an increase in nutrient supply, such as following a meal. Insulin binds to 
the insulin receptor on the plasma membrane which stimulates a complex signaling pathway 
involving insulin receptor substrate proteins (IRS), PI 3-kinase, phosphatidylinositol (3,4,5)P3 
(PIP3), and Akt/protein kinase B, among other intermediates.39,40 This series of reactions 
promotes translocation of vesicles containing GLUT-4 to the plasma membrane, where they
37dock and fuse with the assistance of SNARE proteins.
In addition to increased energy supply in the bloodstream from food sources, increased 
cellular energy demand triggers GLUT-4 translocation. Increased energy demand arises from
37stimuli such as muscle contraction or stress. The exercise-stimulated pathway of GLUT-4
7
regulation is of interest in terms of a potential target for treatment of glucose metabolism 
disorders. This pathway has been examined as a potential target for ‘exercise mimetic’ 
pharmacological therapies.41
2.1.2 Exercise-Stimulation of GLUT-4 in Skeletal Muscle
Murine models provided early information on GLUT-4 content in skeletal muscle tissue 
in response to exercise. When compared to non-exercised control rats, both chronic and acute 
exercise elicit increases in muscle GLUT-4.13,14,42-44 Exercise training increases GLUT-4 content 
in ranges from 30-95%.13,42 Human studies have also demonstrated increased skeletal muscle 
GLUT-4 with acute9,11,21 and chronic exercise.6,12
Since both acute and chronic exercise impact skeletal muscle GLUT-4 content, the 
amount of time between exercise and tissue sampling is a consideration. In human studies, an
acute bout of exercise has been shown to increase plasma membrane GLUT-4 in as little as three
22hours following exercise while others have shown a non-significant increase at eight hours
leading to a significant increase at 22 hours post-exercise.9 Leick et al., on the other hand, failed
21to detect a change in GLUT-4 at 10, 18, or 24 hours following an acute bout of exercise. More 
regular exercise may increase the duration of GLUT-4 upregulation. When compared to their 
untrained counterparts, trained athletes show 93% higher GLUT-4 levels despite no training in 
the two days prior to muscle biopsy. Following four weeks of cycling with one leg only, young
men experience a 36% increase in GLUT-4 in the conditioned leg vs the non-conditioned leg 18
12hours after the last exercise session. Following two weeks of exercise, skeletal muscle GLUT-4 
in young men has been shown to increase 26% over their pre-training levels when biopsies were 
taken 36-48 hours following the last exercise session. It is difficult to draw clear conclusions
8
about the time frame in which skeletal muscle GLUT-4 begins to increase following exercise, 
how long the acute effect lasts, and how long any effect from regular physical activity persists. It 
does, however, appear that the increases begin fairly rapidly following exercise and persist for at 
least one to two days, particularly with a regular exercise protocol.
The specific fiber type of muscles being sampled may impact outcomes. Daugaard et al. 
demonstrated an increase in GLUT-4 in response to exercise in human muscle however when 
muscle-types were separated into slow-twitch or fast-twitch, only the slow-twitch muscles 
showed a response to exercise.
Studies have demonstrated mixed results on the effects of exercise-stimulated GLUT-4 
regulation in subjects with diabetes. After an acute bout of exercise, Kennedy et al. found similar 
increases in plasma membrane GLUT-4 in both diabetic and non-diabetic subjects.11 Likewise, 
Christ-Roberts et al. showed subjects with and without diabetes had similar increases in both 
total and plasma membrane GLUT-4 following eight weeks of exercise.6 Conversely, diabetic 
subjects undergoing strength training exercise show a 40% increase in GLUT-4 in their trained 
leg versus the non-trained leg whereas non-diabetic subjects show no change.10
2.2 Solute carrier family 2 member 4 (SLC2A4) gene
The human SLC2A4 gene, also known as GLUT-4, is located on chromosome 17p13, is 
6,314 base pairs long and codes for the GLUT-4 protein. SLC2A4 activity is primarily reported 
in cardiac and skeletal muscle and adipocytes, however activity in other tissues and cells such as 
brain, kidney, pancreas, liver, and mononuclear cells have also been documented. The central 
role of GLUT-4 in blood glucose regulation, and therefore prevention and control of IR and type 
2 diabetes, makes expression of SLC2A4 of significant interest.
9
Single nucleotide polymorphisms (SNPs) can impact gene function. This poses the 
question of whether SLC2A4 SNPs are associated with IR and/or type 2 diabetes. Early studies 
did not show differences in SLC2A4 genotypes between individuals with versus without 
diabetes.45-50 More recently, several SNPs have shown possible associations with type 2 diabetes 
and/or HbA1c levels including rs265418551,52, rs541252, rs541851-53, rs5 4 3 5 52,53, and rs5421.53 In
52some cases, multiple SNPs present simultaneously are required to see effects. Despite these 
possible associations, research has primarily focused on SLC2A4 transcription without regard to 
genotype.
2.2.1 SLC2A4 Expression and Regulation
Individuals with type 2 diabetes do not necessarily have impaired SLC2A4 expression or 
diminished levels of GLUT-4 however overexpression of the gene can improve glucose 
transport.40 As such, an understanding of the molecular mechanisms of SLC2A4 expression may 
provide insights for pharmacological or lifestyle interventions to improve glucose control.
The promoter region of genes is the primary site for the initiation of transcription. In the 
SLC2A4 gene, several domains within 895 base pairs of the transcription start site have 
demonstrated importance in transcription.54 One of the early regions of focus, that continues to 
be an active area of research, is the myocyte enhancer factor 2 (MEF2) binding region which 
binds multiple isoforms of MEF2.54-65 Additional domains which have regulatory effects include 
an E-box (or hypoxia induced factor 1a, HIF1a) which is involved in MyoD activity,62,65 a 
thyroid response element (TRE) which mediates the effects of thyroid hormones,62,66 the so- 
called Domain I which binds GLUT-4 enhancer factor (GEF),58,63,64 and an NF-kB binding site.67
10
The list of transcription factors and other regulatory molecules interacting with these 
domains continue to grow. MEF2A and MEF2D are essential, but not sufficient for SLC2A4 
transcription.57,68 These two isoforms can exist as a heterodimer. MEF2A is diminished in insulin 
deficiency. A decrease in MEF2A is correlated to a reduction in GLUT-4 protein, pointing to a 
significant role for that particular isoform.68 Despite the importance of MEF2A, other 
biomolecules are necessary for its full functionality. In muscle and cardiac cells, treatment with 
MyoD and TRa1 along with MEF2A dramatically increase transcriptional activity.62 Synergism 
between MEF2A and GEF in SLC2A4 transcription in cultured cells has been demonstrated.56,58 
Weems et al. also note that both MEF2A and GEF are required for full activation of SLC2A4 in 
adipocytes.55 Michael et al. demonstrated that treatment of muscle cells in culture with PGC-1 
proteins (transcriptional coactivators) improve basal glucose transport and increases GLUT-4 
protein both in storage vesicles and on the plasma membrane.59 Mutation of the MEF2 binding 
region ameliorates the increased levels suggesting the effects are a result of increased gene 
expression. Gene-gene interaction may impact SLC2A4 expression. Recently, interaction 
between SLC2A4 and zinc finger protein 407 (Zfp407) has been identified. Knockdown of 
Zfp407 reduces SLC2A4 mRNA, GLUT-4 protein, and insulin-stimulated glucose uptake.
Histones package DNA and play a role in gene expression by mediating chromatin 
remodeling such that transcription factors have more or less ability to bind to a gene. Histones 
can be modified by acetylation, methylation, ubiquitination, sumoylation, phosphorylation, 
glycosylation, and ADP ribosylation, however the most common modifications are acetylation 
and methylation.69 Generally, hyperacetylation causes chromatin to have a more open structure, 
allowing transcription factors access to binding sites and thus increase gene expression; 
hypoacetylation has the opposite effect. There are two primary categories of enzymes involved in
11
histone acetylation: histone deacetylases (HDACs) and histone acetyltransferases (HATs). 
HDACs decrease acetylation and HATs increase acetylation.
The role of histone acetylation has been examined in regard to SLC2A4 transcription. 
There is an inverse relationship between nuclear HDAC5 levels and the expression of GLUT- 
4.55,63 HDAC5 knockdown in mouse and human cell lines increases SLC2A4 expression and
70basal glucose uptake. HDAC5 has been shown to complex with MEF2A and GEF and 
contribute to decreased gene expression even in the presence of these transcription factors, 
supporting a regulatory role for HDAC5.63
Several metabolic signaling systems have been examined for their role in GLUT-4
2+regulation including Ca /calmodulin-dependent protein kinase (CaMK), calcineurin, and 5'
2+AMP-activated protein kinase (AMPK). Calcium (Ca ) release from the sarcoplasmic reticulum
triggers many signaling cascades. Calmodulin is a ubiquitously expressed protein that binds
2+ 2+Ca , allowing it to interact with other molecules. The Ca /calmodulin-dependent protein kinase
II (CaMK II) facilitates phosphate transfer between molecules including from ATP to substrates
and thus is key in energy systems. Calcineurin is also a serine/threonine phosphatase involved in
dephosphorylation which alters a molecule’s activity. 5' AMP activated protein kinase (AMPK)
is a regulator of cellular metabolism and therefore important in muscle tissue. When energy
needs increase, AMPK promotes fatty acid oxidation and glucose mobilization. Therefore
CaMK, AMPK, and calcineurin have potential roles in GLUT-4 regulation.
AICAR is a pharmacological method used in research to stimulate AMPK activity. The
muscle tissues of mice and rats treated with AICAR have increased levels of GLUT-4 protein64
and SLC2A4 mRNA.64,71 These changes may happen in a fiber-dependent manner.64 Zengh et al.
found both the protein and mRNA levels were highest in white fibers of the quadricep (primarily
12
type IIb), elevated in red fibers (primarily IIa), but not elevated in soleus (primarily type I 
fibers).64 It is noteworthy that these changes are time dependent, peaking and returning to normal 
at 13 hours and 24 hours after treatment, respectively.
Evidence supports that the AMPK and CaMK pathways play a role in histone 
deacetylation via HDACs, impacting SLC2A4 regulation. In muscle tissue from the vastus 
lateralis muscle in men, McGee et al. demonstrated AMPK phosphorylates HDAC5 on Ser259 
and Ser498; HDAC5 is subsequently exported from the nucleus allowing increased acetylation of 
the MEF2 binding region triggering increased binding of MEF2A, which results in increased 
SLC2A4 mRNA.54 The authors concluded that HDAC5 is a repressor of SLC2A4 expression via 
HDAC5 phosphorylation by AMPK in skeletal muscle. Mukwevho et al. used caffeine to 
stimulate Ca2+ release in cultured myocytes.60 Stimulation with caffeine causes increased
SLC2A4 mRNA, but that effect is abolished with administration of dantrolene (an inhibitor of
2+calcium release from the sarcoplasmic reticulum), supporting the role of Ca in the signaling 
cascade. Administration of caffeine causes export of HDAC5 from the nucleus, acetylation of 
histone H3, and increased MEF2A binding (no effect on MEF2A quantity), but again, all effects 
are attenuated by dantrolene. In mice, inhibiting the calcineurin, CaMK, or AMPK pathway 
reduces, but does not eliminate, SLC2A4 promoter activity in slow-twitch muscle fibers.61 The 
calcineurin pathway appears to dominate in fast-twitch fibers.61
2.2.2 Exercise-induced SLC2A4 Regulation in Skeletal Muscle
Exercise has been shown not only to increase GLUT-4 translocation to the cell surface of 
myocytes, but also to upregulate SLC2A4 in humans, murine models, and cell culture. In murine
25,26,42,72-74 27,43models, both acute exercise , , , - and chronic training , have increased SLC2A4 mRNA.
13
Other markers of transcription have shown similar results. The upregulation appears to be 
rapid, with mRNA increasing within the first six hours upon cessation of exercise25,26,75 and
25-27,42,72,73maintaining elevation for at least 12 hours following exercise. It is noteworthy that the
exercise protocol of many of these animal studies consists of six hours of exercise on a single
43,72,73,76 43day43,72,73,76 however six hours per day for five days43 or a more modest 60 minutes per day for
28 days27 all resulted in increases in SLC2A4 mRNA.
Human studies have shown increased SLC2A4 mRNA immediately following a single,
22,23,77 22-24hour-long bout of exercise ’ ’ and three hours following such exercise. ' Ninety minutes of
21exercise results in elevated mRNA at ten hours following cessation of exercise, however at
21 15,21eighteen to twenty-four ’ hours following either sixty or ninety minutes of acute exercise, no 
significant changes from baseline are detected. Continuing the sixty minutes per day of exercise 
for seven days also does not cause mRNA to be elevated at 24 hours following completion of the 
final exercise session.15
The transcription factors and signaling pathways involved in SLC2A4 regulation in 
response to exercise continue to be investigated. Murine models have demonstrated increased
25-27MEF2A binding in response to exercise. ' Some studies demonstrate an increase in total 
MEF2A protein43 or MEF2A mRNA74 while others show increased binding, but no increase in 
total protein content25,26 suggesting exercise increases translocation rather than gene 
upregulation. Similarly, in humans, both MEF2A and MEF2D show increased binding 
immediately following a single bout of exercise and nuclear MEF2A, but not MEF2D, increase
78 25following the exercise. In murine models, CaMK II increases immediately following exercise 
and blocking CaMK II activity abolishes the increased MEF2A binding.26 In mice, 
overexpression of AMPK2a increases MEF2A binding; knockout of AMPK2a reduces, but does
75
14
27not eliminate binding. Another study in mice with a mutated AMPK a-subunit did not show
73any difference in SLC2A4 mRNA following exercise compared to wild-type mice. Inhibiting 
calcineurin also has no effect on MEF2A protein content in rats.43 Human data also suggest that
77the calcineurin pathway is not responsible for SLC2A4 activation in response to exercise. These 
data support that exercise increases MEF2A binding to the promoter region of the SLC2A4 gene; 
CaMK II is involved in the signaling for binding and AMPK2a may play a role, but is not 
exclusively responsible. It is noteworthy, however that there may be some variability in
79pathways depending on predominant muscle fiber type in tissues sampled.
A more general look at binding sites and transcripts in murine models have shown
74increased MEF2A, MEF2D, HIF1a mRNA in response to contraction. Additionally, increased
74 80binding activity has been observed at the MEF2 (AT rich element), E-box (HIF1-a), ’ and 
TRa80 sites on the gene. Although NF-kB appears to have a role in insulin-stimulated SLC2A4
74regulation, exercise does not increase NF-kB binding in rat skeletal muscle. Human studies
78demonstrate an immediate increase in GEF binding and MyoD, myogenin, and MRF4
28upregulation in response to a single bout of exercise.
Histone acetylation has been examined for its relationship with SLC2A4 expression. 
Following sixty minutes of cycling, male subjects show no change in total HDAC5 in skeletal
77muscle, but a decrease in nuclear HDAC5 and MEF2 associated HDAC5. Increased
28phosphorylation of HDAC5 at Ser498 is seen after 90 minutes of cycling. Similarly, mice show
27decreased nuclear, but not total, HDAC5 following 28 days of an exercise protocol. It appears
that, in skeletal muscle, exercise stimulates phosphorylation of HDAC5 causing it to translocate
from the nucleus, creating exposure of the MEF2 binding site on the SLC2A4 gene, allowing
binding of transcription factors.
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Most human studies on GLUT-4 in skeletal tissue in response to exercise have utilized 
young, healthy participants, primarily male. This may or may not impact outcomes however 
caution should be used when applying these results to other populations. Conditioning level may 
impact SLC2A4 transcription and GLUT-4 activity. A study of 98 twin pairs showed a positive 
correlation between VO2 max and SLC2A4 mRNA.81 Hussey et al. failed to detect differences in
23SLC2A4 mRNA response to exercise in patients with and without type 2 diabetes. Limited
studies have assessed the role of sex in SLC2A4 gene expression; however, Storgaard et al.
81observed elevated SLC2A4 mRNA in men compared to women. Vissing et al. noted differences
in MEF2A and MEF2D expression in men and women, but other regulatory factors were similar
28between sexes.
2.3 Relationship of Nutrition and GLUT-4 Regulation
The impact of various nutritional factors on GLUT-4 regulation in a wide range of cells
82 83 84 85including cardiac, renal, adipose, and skeletal muscle cells have been investigated. A 
“Western diet” which is high in saturated fat and simple carbohydrates is known to have negative 
metabolic effects. Mice given a Western diet for 16 weeks have no difference in total cellular 
GLUT-4 in cardiac cells than control mice receiving a standard diet, but have decreased plasma 
membrane GLUT-4.82 This suggests decreased translocation and therefore inefficiency of 
GLUT-4. The macronutrient distribution of the diet could potentially impact GLUT-4 
expression. Most human studies on skeletal muscle GLUT-4 changes in response to exercise 
have failed to account for diet. Studies which have provided a standardized diet have varied from
15,22a very high carbohydrate diet (~75% carbohydrates, 15% protein, and 10% fat) ’ to a modest
21carbohydrate diet (53% carbohydrate, 17% protein, 30% fat). These studies yielded different
16
results despite similar participant demographics and exercise protocols. However the time 
interval following exercise that muscle samples were collected were different, therefore it is 
difficult to assess whether the time factor accounts for different results or whether there is 
another contributing factor, such as carbohydrate intake.
Dietary fat intake, and specifically the type of fat, has been investigated for its 
relationship to insulin resistance. Adipocytes incubated with arachidonic acid (AA), an omega-6 
polyunsaturated fatty acid, show increased GLUT-4 protein on the cell membrane without an
84increase in total cell GLUT-4 protein suggesting that AA stimulates GLUT-4 translocation.
This increased GLUT-4 corresponds with increased cellular glucose uptake. Human podocytes in 
cell culture show decreased GLUT-4 translocation in response to insulin and glucose when the
83cells are incubated with palmitate, a saturated fatty acid. Human cultured skeletal muscle cells 
show increased SLC2A4 gene expression when conjugated linoleic acid (CLA), an omega-6 fatty 
acid, or a combination of the omega-3 fatty acids eicosapentaenoic acid (EPA) and
85docosahexaenoic acid (DHA) are given. There was increased glycolytic capacity specifically 
with the omega-3 combination treatment. Cultured skeletal cells incubated with either oleic acid 
(an omega-9 monounsaturated fatty acid) or linoleic acid (an omega-6 polyunsaturated fatty acid) 
show a decrease in both SLC2A4 mRNA and GLUT-4 protein compared to untreated cells.86
Bioactive compounds, often in the form of dietary supplements, have been of interest due 
to availability, consumer interest, and potential potency. Creatine is one such supplement that has 
been heavily researched for its role in exercise. Female rats given creatine, in addition to their 
regular chow, have increased GLUT-4 protein and SLC2A4 mRNA in skeletal muscle compared
87to rats receiving a placebo. The creatine group also exhibit increased nuclear MEF2A and 
MEF2D as well as MEF2 binding. Extracts from Momordica charntia, a plant native to semi-
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tropical climates, given to myocytes in cell culture increases SLC2A4 mRNA 3.6-fold which is
88similar to effects by insulin and rosiglitazone. Blocking protein synthesis negates the effects, 
supporting a role of additional protein production as necessary for upregulation. Resveratrol is 
another bioactive, found in the skin of grapes among other sources, which has been studied for 
its antioxidant and other health-related properties. Chinese men with type 2 diabetes, taking a 
500 mg daily resveratrol supplement for 12 weeks show a trend toward increased expression of
89GLUT-4 in muscle cells compared to controls taking a placebo. The sample size of five per 
group may have been too small to detect significant changes. The activity level of those taking 
the resveratrol was also lower (by chance, not design) which could have modestly attenuated a 
potential effect of the treatment on GLUT-4 levels. It is nonetheless a noteworthy trend for such 
a small sample. These data give reason to consider both food intake and dietary supplements as a 
potential mediator of GLUT-4.
Maternal prenatal diet is known to impact gene expression in offspring, potentially 
affecting multiple generations. Animal models are necessarily used for much of this type of 
research. Female rats born to mothers who were restricted calories during pregnancy to induce 
intrauterine growth retardation (IUGR) have decreased SLC2A4 mRNA in skeletal muscle as 
adults; this is not seen in male offspring.90 The offspring of IUGR dams also have decreased 
MEF2 binding (without a change in MEF2 protein quantity), decreased MyoD binding, and 
decreased histone H3 acetylation. Zheng et al. assessed the impacts of maternal protein 
restriction on GLUT-4 expression and found female offspring have decreased GLUT-4 protein 
and SLC2A4 mRNA, but there no difference in male offspring. Additionally, the female 
offspring have increased MEF2 protein and H3 and H4 acetylation and, again, no change in 
males.91 Increased glucocorticoid exposure during pregnancy in rats has elicited a 15-fold
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increase in SLC2A4 mRNA in skeletal muscle of the offspring. This results in an increase in 
intracellular GLUT-4 protein, however no increase in plasma membrane GLUT-4. A high 
omega-3 fatty acid diet was provided in an attempt to attenuate the effects of the glucocorticoids, 
but no difference was seen. These studies support, not only that prenatal nutrition and 
environment may be an important regulator of GLUT-4 expression, but this may occur in a sex- 
specific manner.
The upregulation of SLC2A4 in response to exercise may be attenuated by dietary factors, 
specifically carbohydrates. Human, male subjects undergoing an acute bout of exercise show 
increased SLC2A4 mRNA in skeletal muscle cells as would be expected, however when they 
ingested a high glucose beverage during exercise and recovery there is a non-significant, but
24noteworthy attenuation of this exercise-stimulated upregulation. Rats subjected to six days of 
exercise training show increased GLUT-4 protein, increased MEF2A binding to SLC2A4, 
increased histone H3 acetylation, decreased nuclear HDAC5, and increased pAMPK/AMPK in
93skeletal muscle cells, all of which are consistent with other exercise studies. However, some 
groups of rats in this study were provided access to either a high fructose beverage, a high 
maltodextrin beverage, or plain water (in addition to standard rat chow). Both of the sugar 
beverages attenuated the exercise-induced increases in GLUT-4, MEF2A binding, and histone 
H3 acetylation; the fructose beverage attenuated the phosphorylation of AMPK and the decrease 
in HDAC5. These studies suggest that simple sugars may negate some of the beneficial effects of 
exercise in terms of GLUT-4 regulation.
Nutritional intake may indeed impact GLUT-4 regulation in a variety of cell types 
independently, or more likely, interacting with other modulating mechanisms. Specific types of
92
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fats, sugars, and other bioactive compounds as well as overall dietary patterns warrant 
investigation.
2.4 GLUT-4 in Peripheral Blood Mononuclear Cells (PBMC)
As long as four decades ago, it was recognized that human PBMCs contain insulin 
receptors and bind insulin in a quantity relative to the number of monocytes.94 Monocytes were 
found to be the major subpopulation of PBMCs to bind insulin, accounting for approximately
2980% of insulin binding activity within PBMCs. More recently, lymphocytes have shown to be 
responsive to insulin as well.34 GLUT-4 is present in PBMCs.17 Similar to insulin binding 
activity, monocytes appear to have the most GLUT-4 activity among PBMCs.31,34,95 Monocytes 
treated with insulin increase GLUT-4 on the plasma membrane from 24-54%.96-98
The impact of obesity and insulin resistance disorders such as type 2 diabetes appear to 
decrease insulin binding to monocytes similar to what is observed in myocytes and 
adipocytes.99,100 As would be predicted based on activity in other cell types, glucose clearance is 
increased with increased insulin binding.100 A reduced quantity of GLUT-4 has been seen in 
monocytes of diabetic patients compared to healthy controls however the SLC2A4 mRNA is no 
different between the groups.101 Lymphocytes also show GLUT-4 activity similar to myocytes 
and adipocytes. Subjects with pre-diabetes have decreased lymphocyte GLUT-4 levels compared 
to their euglycemic peers. Interestingly, the GLUT-4 levels of euglycemic subjects with a 
family history of type 2 diabetes mimic their pre-diabetic counterparts. This pattern would fit 
with the pathophysiology of diabetes whereby insulin levels increase in the early stages 
attempting to compensate for slight elevations in blood glucose. The increased insulin stimulates
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increased GLUT-4 activity. The interesting finding is that this pattern is observed in PBMCs 
similar to other insulin-sensitive tissues.
Despite decades of data demonstrating that mononuclear cells express insulin-stimulated 
GLUT-4 activity, research has not focused on exercise-stimulated GLUT-4 activity in this cell 
population. PBMCs are an attractive cell type for such research due to their ease of accessibility 
for study as well as their role in immunity and inflammation, which is now a well-understood 
component of metabolic disorders.
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Chapter 3: Materials and Methods
3.1 Study Design
This study used a cross-sectional design of participants who were students at the 
University of Alaska Fairbanks (UAF) at the time of the study.
3.1.1 IRB and Consent
The study protocol was approved by the Institutional Review Board of the University of 
Alaska Fairbanks (#492213-4) and acknowledged by the Institutional Review Board of the 
University of Alaska Anchorage (Appendix A). Written consent was obtained prior to beginning 
data collection.
3.1.2 Participants
All participants were students at UAF, between 18 and 25 years of age, non-pregnant, 
and non-diabetic. The sample consisted of two groups: conditioned athletes and sedentary 
students. Conditioned participants were recruited through the UAF cross-country skiing and 
cross-country running teams. This group consisted of endurance athletes who had been training 
for ten to twenty hours per week for three months prior to sample collection. Exercise training 
involved both team and individual plans, but was designed to prepare athletes for competition in 
cross-country running and/or cross-country skiing between September and March. Sedentary 
participants were recruited through a variety of ways including speaking to introductory level 
science classes, posting flyers around campus, and through social media such as UAF’s 
Facebook and Pinterest pages. Sedentary students did not participate in regular moderate
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physical activity (defined to participants as “physical activity that takes moderate effort and 
makes you breathe somewhat harder than normal”) for more than 20 minutes one time per week 
over the past three months. Sedentary students were pre-screened using a questionnaire created 
and administered through google forms.
Participants completed a health history questionnaire which included demographic 
information such as age, sex, and ethnicity (Appendix B). The health history confirmed there 
was no known history of diabetes. Participants were 90% white.
3.2 Dietary, Physical Activity, and Biometric Assessment
Dietary and physical activity data and body measurements were collected at one time 
during the study. Participants were instructed to record their dietary intake as described below 
and complete the physical activity questionnaire prior to presenting to the clinic for the biometric 
assessment and blood draw. Participants presented to the clinic in the morning following an 
overnight fast.
3.2.1 Dietary Assessment
Dietary data was collected using the ASA24 Automated Self-Administered 24-hour 
Recall system from the National Cancer Institute. The ASA24 is a computer-based system 
modeled after the USDA Automated Multiple Pass Method (AMPM) which is used in the 
National Health and Nutrition Examination Survey (NHANES). The ASA24 has been shown to 
have acceptable performance in measuring true intake and is comparable to an interviewer-
102 103administered 24-hour recall in populations such as the one sampled for this study. ’
Participants were instructed on the tool following informed consent. They were asked to record
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one typical weekend day and one typical weekday of food intake. Dietary data was reviewed and 
cleaned according to ASA24 recommendations. Specific nutrients and food groups were 
analyzed for similarities between the two groups and for any association with GLUT-4 protein or 
SLC2A4 gene expression. Fruit and vegetable intake, total calories, macronutrient distribution, 
sugar, fiber, saturated fat, arachidonic acid, palmitate, oleic acid, and linoleic acid were analyzed.
3.2.2 Physical Activity Assessment
Participants completed the International Physical Activity Questionnaire (IPAQ) Short 
Form with instructions from a researcher (Appendix C). The IPAQ has been assessed for validity 
and reliability in multiple populations.104 The data in the questionnaires were analyzed and 
cleaned according to the IPAQ Guidelines for Data Processing and Analysis. MET-minute/week 
scores were calculated and participants were classified categorically according to the protocol as 
low, moderate, or high physical activity levels.
3.2.3 Biometric Assessment
A Registered Nurse with the Center for Alaska Native Health Research performed 
anthropometric measurements. Height was measured to the nearest 1/8 inch. Weight in pounds 
and percent body fat were measured with a TANITA TBF-300A (Tanita Corporation of America 
Inc., Arlington Hills, Illinois); shoes, socks, and heavy clothing were removed. The “standard” 
setting on the TANITA was utilized regardless of physical activity level for consistency in 
measurements. Waist circumference was measured with the Gulick II 150 cm anthropometric 
tape. Two measurements to the nearest 0.2 cm were obtained and the average was utilized in the 
analysis. If measurements differed by more than two cm an additional measurement was taken.
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3.3 Laboratory Assessment
Participants were instructed to fast for 12 hours prior to the blood draw with nothing 
consumed except water. Blood was obtained by venipuncture into one 8-ml BD separation tube, 
one 4-ml EDTA tube, and one 2-ml heparinized tube. Samples not immediately used were 
refrigerated or centrifuged within two hours of sample collection. Plasma from heparinized tubes 
was frozen at -80° C for future measurement of insulin.
3.3.1 Metabolic Parameters
Blood lipids, glucose, and HbA1c were measured immediately following each blood 
draw utilizing blood from the heparinized tube at UAF’s Center for Alaska Native Health 
Research clinic. The Cholestech LDX system measured total cholesterol, LDL, HDL, 
triglycerides, and glucose; the Bayer DCA 2000+ Analyzer measured HbA1c.
Plasma insulin was measured using a commercially available ELISA kit. Tests were run 
in duplicate. The Insulin ELISA (ALPCO Immunoassays, United States) kit was used according 
to manufacturer’s instructions; absorbance was read at 450 nm. Absorbance readings were 
collected using a Synergy HT multi-mode microplate reader (BioTek, United States).
The homeostasis model assessment of insulin resistance (HOMA-IR) has been widely 
used as a surrogate for assessing insulin resistance however universal cut-off values have not 
been defined.105-108 HOMA-IR was calculated with the equation (fasting plasma insulin * fasting 
plasma glucose)/22.5.105-108
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3.3.2 GLUT-4 Protein
The BD separation tubes were centrifuged at 3600 RPM for 15 minutes at room 
temperature. The mononuclear cell layer was then collected and transferred to a 15-mL conical 
vial. The sample was re-suspended in 15 mL RPMI 1640. Tubes were centrifuged for 15 minutes 
at 1500 RPM. Samples were washed 2 times and centrifuged for 15 minutes at 1500 RPM after 
each wash. The final sample was re-suspended with RPMI 1640 to a final volume of 8 mL from 
which the sample for the GLUT-4 protein analysis was drawn.
The GLUT-4 protein was measured using a commercially available ELISA kit. Tests 
were run in duplicate. The Glucose Transporter 4 (GLUT-4) kit (USCN Life Sciences, Inc., 
United States) kit was used according to manufacturer’s instructions; absorbance was read at 450 
nm. Absorbance readings were collected using a Synergy HT multi-mode microplate reader 
(BioTek, United States).
3.3.3 Genomic Labs
The genomic lab experiments were designed to assess differences in MEF2 and HDAC5 
binding to the SLC2A4 promoter region and relative quantities of SLC2A4 mRNA between the 
conditioned and sedentary groups. The goal was to determine whether patterns were similar to 
what has been observed in myocytes.
Chromatin Immunoprecipitation. Chromatin was isolated from the mononuclear cells 
with a commercial chromatin extraction kit (Abcam Episeeker Chromatin Extraction Kit). The 
cells from approximately 3 ml of whole blood were utilized. The BD separation tubes yield 
approximately 1.3 million PBMCs per 1 ml whole blood. This value was used to estimate cell 
quantity for experiments. The manufacturer’s protocol for suspension cells was followed
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assuming approximately 3 x 106 cells. The protocol estimated a yield of 4 |ig of chromatin per 
106 cells, therefore it was estimated that the current chromatin extraction yielded approximately 
12 ^g of chromatin.
The estimated 12 |ig of chromatin was utilized for chromatin immunoprecipitation with a 
commercial ChIP kit (AbCam EpiSeeker ChIP Kit -  One Step). MEF2 and HDAC5 were 
immunoprecipitated using commercially available antibodies (Santa Cruz Biotechnolog, Inc). 
The manufacturer’s protocol was followed for the ChIP reaction using RNA polymerase II as a 
positive control and IgG as a negative control. Concentrations were quantified with a nanodrop 
machine to move forward with real time RT-PCR. Unfortunately, there were undetectable 
quantities of DNA in the samples, therefore the subsequent planned experiment to analyze 
quantities of MEF2 and HDAC5 binding to the promoter region of SLC2A4 was not carried out.
SLC2A4 mRNA. RNA was extracted from the mononuclear cells from approximately 3 
ml of whole blood (with an estimated 1.3 million cells per ml of whole blood as previously 
described). The TRIzol (Life Technologies) reagent and protocol was utilized. The interphase 
containing protein and DNA was stored at -80° C for later analysis. Extracted RNA was 
quantified using the nanodrop machine. cDNA was synthesized using First Strand cDNA 
Synthesis protocol (Life Technologies/ The RNA volume added to each reaction was adjusted 
based on the concentration of RNA in the sample such that 1 |ig RNA was utilized for each 
cDNA synthesis reaction.
The real time RT-PCR experiment was set up with 1 |il of cDNA in each reaction. 
Reactions were run in triplicate. GAPDH was used as an internal control (“housekeeper 
gene”).109,110 Real time RT-PCR was performed using SYBR green chemistry on the Step One 
Plus RT PCR System (Applied Biosystems). Primers were designed to amplify the MEF2
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binding region of SLC2A4 (forward: 5'-CCT GAC ATT TGG AGG CTC-3'; reverse: 5'-GGA 
GCA ATG CCC CAA AG-3').54 Forty cycles of PCR were utilized for amplification. 
Experiments with a standard deviation between triplicates of greater than 1.0 were repeated until 
acceptable standard deviations were achieved. Relative quantification was conducted by 
expressing the cycle threshold (CT) values for SLC2A4 relative to the GAPDH internal control.
As will be presented in the results section, GAPDH did not show consistent expression between 
the two groups in this study, despite literature that suggests it is an appropriate internal control 
for SLC2A4.109’110 Because of this, the log transformation of the actual CT (2-CT) was used for 
further analysis.
GLUT-4 Enhancer Factor (GEF) and GLUT-4 Protein Analysis. The TRIzol protocol 
was utilized to isolate protein from the interphase saved from the RNA isolation described 
above. Protein was re-suspended in SDS according to protocol and stored at -20° C until protein 
quantification. Protein was quantified using the Lowry protocol with the RC DC™  (reducing 
agent and detergent compatible) Protein Assay (Bio Rad) using 25 |il of sample.
SDS-PAGE and immunoblotting were performed using standard techniques. A 10% 
SDS-PAGE gel was utilized. The quantity of sample loaded onto the gel was calculated based on 
the initial protein concentration to provide a loading concentration of 0.8 mg/ml in a total volume 
of 20 ^l of loading solution. The protein yield of many samples in the initial batches of 
experiments was very low. When the stock of isopropanol was replaced, the subsequent 
experiments had a visually identifiable difference in the protein pellet following that step and a 
more expected protein yield which led to the conclusion that the isopropanol used for the initial 
batches of experiments was most likely the problem in the initial experiments. For this reason, 
only nine samples were used for the remaining protein experiments. Even of the nine remaining
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samples, protein concentrations of some were limited; 0.8 mg/ml was selected as the highest 
concentration that could be obtained from all remaining samples. After SDS-PAGE, 
immunoblotting was done with anti-glucose transporter GLUT-4 antibody (Abcam) and anti- 
SLC2A4RG antibody (Abcam). Membranes were incubated with primary antibodies overnight at 
4°C with gentle shaking. Secondary antibodies were species-specific (anti-rabbit antibody for 
anti-SLC2A4RG/GEF and anti-mouse for anti-GLUT4) horseradish peroxides-conjugated 
immunoglobulins. Multiple concentrations of primary and secondary antibodies were used in an 
attempt to optimize the Western blot (See Appendix D for details of attempts at experiment 
optimization). SuperSignal™ West Femto Maximum Sensitivity Substrate (Life Technologies) 
was used for chemiluminescent imaging.
3.4 Statistical analysis
SPSS statistical analysis software (version 21) was used to analyze the data. Student’s 
independent sample t-tests were used to assess differences between the conditioned and 
sedentary groups (differences were considered significance at a  < 0.05) related to demographic, 
anthropometric, biochemical, and dietary data. Student’s independent t-tests were also used to 
assess differences in GLUT-4 and SLC2A4 between males and females. The SPSS box-plot was 
used to assess outliers, the Shapiro-Wilk test to assess normal distribution of the data, and 
Levene’s test to assess homogeneity of variances prior to conducting the t-test. The Mann- 
Whitney U test was used to assess physical activity data between the groups and non-parametric 
data. Pearson’s correlation coefficient or Spearman’s rank correlation coefficient on the 
combined groups were used to investigate associations between GLUT-4 and glucose, HbAlc, 
insulin, HOMA-IR, BMI, percent body fat, and dietary factors.
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Chapter 4: Results
4.1 Demographics
Conditioned participants had a mean age of 20.1± 2.0 years and the sedentary participants 
had a mean age of 21.5 ± 2.1 years. There were no significant differences between the groups in 
regard to age or sex (Table 1).
TABLE 1: Demographics
Parameter Conditioned Sedentary
~n 16 15
Age (years) 20.1 ± 2.0 21.5 ± 2.1
Sex:
Male 8 8
Female 8 7
Demographic data as reported on health history form.
Data are means + standard deviations.
No significant differences between groups for age or sex.
4.2 Diet, Physical Activity, and Biometric Assessment
Diet intake, physical activity, and body measurements were assessed. These indicators 
were analyzed for similarities and/or differences between groups as well as correlations with 
GLUT-4.
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4.2.1 Diet Assessment
Dietary factors related to blood glucose regulation were analyzed (Table 2). There was no 
significant difference in macronutrient distribution between the two groups. The conditioned 
group had a significantly higher total caloric intake (p=0.004), sugar intake (p=0.002), fiber 
intake (p<0.0001), and fruit and vegetable intake (p=0.005) than the sedentary group. When 
sugar, fiber, and fruit and vegetable intake were normalized to individual caloric intake, there 
was found to be no significant difference in mean grams of sugar per calorie between the groups 
(p=0.461). Servings of fruit and vegetables and grams of fiber intake per calorie were non- 
normally distributed therefore mean ranks were analyzed using a Mann-Whitney U test. The 
conditioned group had a higher mean rank of gram of fiber per calorie intake (19.97) than the 
sedentary group (11.77), U  = 56.500, z = -2.551, p=0.011. The conditioned group also had a 
higher mean rank of servings of fruits and vegetables per calorie intake (19.25) than the 
sedentary group (12.3), U  =68.000, z = -2.055, p=0.041. Using Pearson’s correlation coefficient, 
no associations between GLUT-4 and calories, sugar, fiber, or fruit and vegetable intake could be 
detected.
TABLE 2: Calorie, Macronutrient, and Fruit/Vegetable Intake 
Parameter Conditioned Sedentary p-value
Mean Mean
5R
Fruit and Vegetable Intake 3.8 (2.2) 1.9 (1.1) 0.005
(servings/day)
Caloric Intake (kcal/day) 3022 (951) 2041 (756) 0.004*
Calories from Carbohydrate (%) 51.7 (5.1) 47.5 (6.8) 0.060
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TABLE 2 Cont.
Calories from Fat (%) 34.5 (3.9) 35.6 (5.2) 0.488
Calories from Protein (%) 15.4 (2.1) 14.3 (2.7) 0.223
Sugar Intake (g/day) 171.5 (63.2) 104.7 (46.0)
*0.002*
Fiber Intake (g/day) 29.0 (11.2) 14.2 (7.5) < 0.0001
Dietary data as assessed by ASA24 program. Data are reported as means (standard deviations).
* significant at p <0.05
83 84 86Based on findings of other studies, ’ ’ correlations between specific types of fat and 
GLUT-4 were analyzed. For both groups combined, a scatterplot showed no relationship 
between GLUT-4 and saturated fat, arachidonic acid, palmitate, oleic acid, or linoleic acid 
(Figures 1-5). The intake of these fats within the conditioned group was normally distributed, 
however in the sedentary group only arachidonic acid and oleic acid were normally distributed. 
For this reason, and to control for conditioning, the conditioned group was analyzed separately as 
well. Still, no associations between these fatty acids and GLUT-4 could be detected.
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FIGURE 1: Relationship Between GLUT-4 Protein and Arachidonic Acid Intake
There is no association between GLUT-4 protein and arachidonic acid intake in the combined groups.
FIGURE 2: Relationship Between GLUT-4 Protein and Saturated Fat Intake
There is no association between GLUT-4 protein and saturated fat intake in the combined groups.
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FIGURE 3: Relationship Between GLUT-4 Protein and Palmitate
There is no association between GLUT-4 protein and palmitate intake in the combined groups.
FIGURE 4: Relationship Between GLUT-4 Protein and Linoleic Acid Intake
There is no association between GLUT-4 protein and linoleic acid intake in the combined groups.
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FIGURE 5: Relationship Between GLUT-4 Protein and Oleic Acid Intake
There is no association between GLUT-4 protein and oleic acid intake in the combined groups.
4.2.2 Physical Activity Assessment
Despite a pre-screening of participants for physical activity levels, the International 
Physical Activity Questionnaire (IPAQ)-Short Form indicated that some of the participants in the 
sedentary group did in fact have moderate or high physical activity levels. A Mann-Whitney U 
test was conducted to determine if there were significant differences in physical activity, as 
assessed by the IPAQ-Short Form, between the two groups. MET-minutes per week were 
calculated which estimates the total energy cost of physical activity for a given week. Based on 
this calculation, participants were categorized as having low, moderate, or high activity levels. 
The distributions of MET-minutes per week and the categorical ranking of physical activity 
levels were different between groups, therefore median values could not be accurately compared, 
but mean ranks could be. The mean ranks between groups showed statistically significant 
differences for both methods of analyzing the IPAQ data (MET-minutes and categorical ranking
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of physical activity). For MET-minutes per week, U=7.00, p<0.0005; for categorical physical 
activity levels, U=17.5, p<0.0005, using an exact sampling distribution for each. These data 
confirm that the physical activity levels between groups were in fact highly significantly 
different which was intended in the study design.
4.2.3 Biometric Assessment
Of all anthropometric measurements (Table 3), there was only a single significant 
difference between the groups for Body Mass Index (p=0.05). All of the participants in the 
conditioned group had a BMI in a healthy range (18.6-25.0). In the sedentary group, ten 
participants had a healthy BMI, three were overweight (BMI = 25-29.9), and two were obese 
(BMI >30). There was no difference between groups for any other anthropometric 
measurements, however percent body fat and waist circumference trended toward significance (p 
= 0.10 and 0.06, respectively).
TABLE 3: Body Mass and Composition
Parameter Conditioned
Mean
Sedentary
Mean
p-value
Body Mass Index (kg/m ) 21.7 (1.8) 24.8 (5.3) 0.05
Body Fat (%) 17.2 (8.0) 22.4 (8.9) 0.10
Waist Circumference (cm) 72.9 (5.8) 80.7 (13.9) 0.06
Basal Metabolic Rate (kcal/day) 1616 (212) 1718 (330) 0.31
Data are reported as means (standard deviations).
* p < 0.05; others non-significant at p > 0.05
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4.3 Laboratory Assessment
The laboratory assessment evaluated metabolic parameters as well as GLUT-4 protein 
and SLC2A4 gene expression in PBMCs.
4.3.1 Metabolic Parameters
There were no significant differences between the groups for glucose, HbA1c, insulin, or 
HOMA-IR (Table 4) although insulin and HOMA-IR approached significance (p = 0.14 and
0.15, respectively).
TABLE 4: Glucose, Insulin, HbA1c, and HOMA-IR Comparison
Parameter Conditioned
Mean
Sedentary
Mean
p-value
Glucose (mg/dl) 90.8 (8.1) 93.4 (10.4) 0.43
HbA1c (% / mmol/mol) 5.1/32 (0.3) 5.0/31 (0.2) 0.49
Mean Rank1" Mean Rank
Fasting serum insulin 13.66 18.50 0.14
(pIU/ml)
HOMA-IR* 13.69 18.47 0.15
Data are reported as means (standard deviations).
No significant differences between groups were identified for the glucose and insulin-related measures. 
f Serum insulin and HOMA-IR had non-normal distributions therefore the Mann-Whitney U test was 
conducted. For both measures, the distributions between groups were not similar as assessed by visual
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inspection therefore mean ranks were compared for analysis. For insulin U = 157.5, z = 0.483; for HOMA- 
IR U = 157.00, z = 1.436
* HOMA-IR calculation: [fasting serum glucose (mmol/L) * fasting serum insulin ( I^U/ml)] / 22.5
Total cholesterol, LDL, HDL, and triglycerides also were not different between groups 
(Table 5), but HDL and triglycerides approached significance (p = 0.10 for both parameters). It is 
noteworthy that the Cholestech LDX which was used to measure lipid levels only detects 
triglycerides down to 45 mg/dl. LDL is calculated with the Friedwald formula using 
triglycerides. Six conditioned participants and two sedentary participants had undetectable levels 
of triglycerides with the methodology used. A value of 22.5 mg/dl was used (the midpoint 
between zero and the lowest detectable concentration) for those participants. This adds a level of 
error to both the triglyceride and LDL values so those data should be interpreted with caution.
TABLE 5: Serum Lipids in Participant Groups
Parameter Conditioned
Mean
Sedentary
Mean
p-value
Total Cholesterol (mg/dl) 167.4 (25.3) 168.0 (24.2) 0.95
LDL (mg/dl)+ 95.5 (32.8) 95.3 (16.9) 0.99
HDL (mg/dl) 68.0 (10.2) 59.5 (17.4) 0.10
Mean Ranki Mean Rank
Triglycerides (mg/dl)+ 13.38 18.80 0.10
Data are reported as means (standard deviations).
No significant differences between groups were identified for lipids.
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f 45 mg/dl is the lowest detectable level of triglycerides with the Cholestech LDX; LDL is calculated with 
the Friedewald formula using triglycerides. For participants with triglycerides lower than the detectable 
limit, a value of 22.5 was assigned and LDL was calculated using that value. This was done for six 
participants from the conditioned group and two participants from the sedentary group.
* Triglycerides had a non-normal distribution therefore the Mann-Whitney U test was conducted. The 
distributions between groups were not similar as assessed by visual inspection therefore mean ranks were 
compared for analysis. U = 162.000 , z = 1.675
4.3.2 GLUT-4 Protein
The conditioned group had a higher GLUT-4 on PBMC in fresh samples than the 
sedentary group; that difference was not statistically significant, but approached significance 
(p=0.07) (Figure 6). The conditioned group (n=16) had a mean of 0.6433 ng/mL ± 0.2871 
compared to the sedentary group (n=13 due to sample loss) mean of 0.4057 ng/mL ± 0.3889.
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FIGURE 6: PBMC GLUT-4 Protein in Conditioned vs. Sedentary Participants
GLUT-4 measured in ng/mL. The conditioned group had higher PBMC GLUT-4 on the cell surface than 
the sedentary group, although it was non-significantly different (p = 0.07).
Females showed a higher mean GLUT-4 than males (0.7161 ng/mL vs. 0.3911 ng/mL) in 
the combined groups (p=0.01) (Figure 7) and the sedentary group (0.6813 ng/mL vs. 0.2335 
ng/mL; p=0.036). In the conditioned group, GLUT-4 levels in females were higher than males 
(0.7379 ng/mL vs. 0.5488 ng/mL), although the difference was not significant (p=0.197).
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FIGURE 7: PBMC GLUT-4 Protein in Males vs. Females
GLUT-4 measured in ng/mL. Females from combined groups of participants had higher PBMC GLUT-4 
on the cell surface than males (p = 0.01).
Pearson’s correlation coefficient or Spearman’s rank correlation coefficient were used to 
assess correlations between GLUT-4 and glucose, HbA1c, fasting insulin, HOMA-IR, BMI, and 
percent body fat. None of the parameters assessed showed a correlation with GLUT-4.
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SLC2A4 mRNA was evaluated using real-time RT PCR. The CT provides information on 
relative quantities of mRNA in the samples. GAPDH was utilized as an internal control.
The CT for GAPDH was evaluated based on the methodology of Schmittgen and Livak to 
assess the quality of GAPDH as an internal control.111 In this process, the CT was log
C Ctransformed to 2' T. The ratio of the 2' Tbetween the conditioned and sedentary groups is 21.87 
showing approximately a 22-fold higher expression in the conditioned group. This demonstrates 
that GAPDH is not a good internal control for evaluating effects of endurance exercise training. 
Unfortunately, there was insufficient sample to do an additional analysis with a different internal 
control gene. Subsequent analysis, therefore, uses the 2' T from the SLC2A4 RT PCR without use 
of the GAPDH. Using this same methodology of calculating the ratio between the conditioned 
and sedentary group, the conditioned group showed a 15-fold higher expression of SLC2A4 than 
the sedentary group.
The relative quantities of SLC2A4 mRNA, as evaluated by PCR, show that no groups 
have normal distribution of the 2' T values. Therefore the non-parametric Mann-Whitney U was 
used for analysis. By visual inspection of a histogram of the data, it does not appear that the data 
have the same shape therefore median values could not be compared, but mean ranks can. The 
mean rank of the conditioned group was 18.27 and the sedentary was 8.67 (p= 0.001). This 
indicates a difference in the distributions of the mean gene expression between the groups 
(Figure 8).
4.3.3 Genomic Labs
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FIGURE 8: SLC2A4 mRNA Analysis for Conditioned vs. Sedentary Groups
The distribution of mean ranks for the conditioned vs. sedentary groups is significantly different (p=0.001).
Like the analysis between the conditioned and the sedentary groups, an analysis between 
sexes also shows a non-normal and non-similar distribution therefore mean ranks were 
compared. The mean rank was 13.25 for females and 14.60 for males showing no difference in 
distribution of mean gene expression between sexes (0.683) (Figure 9).
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FIGURE 9: SLC2A4 mRNA Analysis for Females vs. Males
The distribution of mean ranks is no different between sexes (p=0.683).
SLC2A4 mRNA was analyzed for an association between gene expression and dietary 
intake of specific nutrients and food groups including caloric intake, percent of calories from 
carbohydrate, fruit and vegetable servings, and intake of sugar, fiber, saturated fat, arachidonic 
acid, palmitate, oleic acid, and linoleic acid. None of these dietary variables show any type of 
relationship or association with SLC2A4 mRNA.
SDS-PAGE with subsequent western blot was used to analyze GLUT-4 enhancer factor 
(GEF) between groups. Due to insufficient yield of protein in many samples, samples from only 
six of the conditioned group and three of the sedentary group were able to be used for analysis. A 
successful western blot showing clear GEF was not obtained.
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Chapter 5: Discussion and Conclusions
5.1 GLUT-4 Levels in Conditioned vs. Sedentary College Students
The present study compared GLUT-4 protein on PBMCs of conditioned and sedentary 
college students. These results were compared to two primary lines of literature: one which 
demonstrates that GLUT-4 is elevated in skeletal muscle tissue in response to exercise and a 
second which demonstrates PBMC GLUT-4 responds to insulin in a similar way that skeletal 
muscle responds to insulin. The goal was to determine whether to further evaluate PBMC as a 
proxy tissue for skeletal muscle for the study of GLUT-4.
The findings of this study demonstrate a non-significant, but noteworthy, difference in 
GLUT-4 on PBMC in conditioned compared to sedentary individuals. The conditioned athletes 
had higher GLUT-4 protein than their sedentary peers. Muscle biopsies were not obtained in this 
study so it cannot be concluded definitively that PBMC GLUT-4 quantity is a direct reflection of 
skeletal muscle GLUT-4 quantity, however the results do suggest this is a plausible hypothesis.
Samples for this study were obtained in the morning following a day of intense training 
for the conditioned group. Although a specific time frame following exercise was not built into 
the study design, it is known that the athletes reported for their blood draws approximately 15-19 
hours following their last training session. The literature on the initiation of GLUT-4 elevation in 
skeletal muscle following exercise and the duration of maintenance of that elevation is 
inconclusive. Elevations may begin as early as three hours following exercise and may persist for 
as long as 36 hours. The time frame of blood draws for the current study are within that range, 
but it is difficult to predict whether analysis of PBMCs collected sooner after the training would 
have yielded higher or lower GLUT-4 levels.
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Many studies on GLUT-4 changes in skeletal muscle in response to exercise do not 
account for variables such as body composition or dietary intake. In the current study, the 
sedentary group had a significantly higher BMI and a trend toward higher percent body fat and 
waist circumference than the sedentary group. The mean BMI within the sedentary group was 
however still within a “healthy weight” range (mean BMI 24.8). It cannot be ruled out that 
differences in body composition and weight had an impact on GLUT-4 quantity.
As would be expected from collegiate athletes, the calorie intake of the conditioned group 
was significantly higher than the sedentary group. Their fruit and vegetable and sugar intake was 
also significantly higher and the percent of calories from carbohydrates was higher although non­
significantly (p=0.06). Intake of calories, and particularly sugar and carbohydrates, stimulate 
insulin release. The study design did not provide a way to control for the possibility that 
increased GLUT-4 levels in the athletes were not somehow related to these dietary differences. 
The blood draws for PBMC analysis were conducted in a fasting state (minimum of 12 hours) so 
it would be expected that insulin stimulation from dietary intake would no longer be present. 
Nonetheless, the substantial difference in calorie and carbohydrate intake between the two 
groups is a limitation of the current study design yet one that could not be avoided when looking 
at groups with vastly different activity levels.
This study was limited by the fact that muscle biopsies were not obtained to directly 
compare muscle GLUT-4 to PBMC GLUT-4. Comparing the results to the existing literature 
however suggest that there may be a correlation between these two. Future studies with a design 
that allows for direct comparison are warranted. Using participants as their own control with pre- 
and post-exercise measures would help control for individual variabilities in factors such as 
caloric intake and body composition.
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5.2 Correlation between PBMC GLUT-4 and Common Indicators of Insulin Resistance
Direct and indirect methods for assessing insulin sensitivity have been described.106 The 
hyperinsulinemic euglycemic glucose clamp is a direct measure of insulin resistance. Using this 
procedure, after an overnight fast the individual would receive an insulin infusion at a constant 
rate. Simultaneously, a dextrose infusion would be given while sampling blood glucose levels 
every 5 to 10 minutes. The dextrose would be adjusted to keep blood glucose levels in a 
euglycemic range. A steady state must be achieved in this test which can take several hours. In 
these study conditions, the glucose infusion rate (GIR) should equal the glucose disposal rate 
since the test design is such that blood glucose levels are maintained. Clearly, this methodology 
is invasive and time consuming and therefore is not used in the clinical setting.
One of the most commonly used clinical methods for assessing insulin resistance is by 
assessing glucose tolerance. It is important to recognize that glucose intolerance and insulin 
resistance are not the same; however when assessing insulin resistance in a clinical setting the 
core question is typically whether the individual is able to maintain euglycemia regardless of 
glucose intake. An oral glucose tolerance would be used for this assessment.
Several surrogates of insulin resistance can be used clinically as well. One common 
method is to take fasting blood glucose and insulin levels. These values are then mathematically 
used to estimate insulin resistance. One limitation on any mathematical models using fasting 
insulin and glucose are that they only represent hepatic glucose and insulin utilization since they 
are taken in a basal state. In healthy individuals with normal glucose metabolism, this is going to 
be similar to peripheral insulin and glucose utilization, but in individuals with glucose 
metabolism disorders (such as diabetes or hypoglycemia) this may not be true. Another
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limitation is that the lack of a standardized insulin assay prevents the development of standard 
cut-off values for diagnostic criteria.
The homeostasis model assessment for insulin resistance (HOMA-IR) is one commonly 
used surrogate based on a mathematical model. The calculation for HOMA-IR is {[fasting 
insulin (^U/ml) x [fasting glucose (mmol/l0]} / 22.5. The 22.5 is a normalization factor which 
takes into account “normal” fasting glucose and “normal” fasting insulin levels. In a person with 
normal insulin sensitivity, the HOMA-IR would be about 1 due to normalization in the 
mathematical model with the 22.5. Fasting levels of insulin are not linear and therefore another 
methodology is to calculate log (HOMA-IR). This may be more accurate in individuals with 
abnormal glucose tolerance or insulin sensitivity.
The present study used fasting glucose, insulin, HbAlc, and HOMA-IR to assess IR. A 
limitation of this study is that the direct measure of IR using a hyperinsulinemic euglycemic 
glucose clamp was not used. No difference between the two groups was found for any of the 
glucose or insulin parameters suggesting both groups had similar metabolic utilization of 
glucose. There was no correlation between PBMC GLUT-4 levels and any of the indicators of 
insulin resistance utilized in this study. This suggests that PBMC GLUT-4 may not be a good 
measure of insulin resistance in this population. It should be noted, however, that insulin and 
HOMA-IR data were non-normally distributed and a larger sample population may yield 
different results. There was no clinical indication of diabetes or pre-diabetes in any participant; 
individuals with impaired glucose tolerance may show different results. The findings of this 
study do not support PBMC GLUT-4 as a measure of insulin resistance however a modified 
study and participant sampling design may be warranted for further investigation.
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5.3 Increased Transcription of SLC2A4 in Conditioned vs. Sedentary College Students
The results of the present study, while not definitive, suggested a higher level of GLUT-4 
protein in the conditioned participants compared to the sedentary. The next question of interest 
was whether genomic analysis would demonstrate that increased transcription of SLC2A4 played 
a role in the mechanism of action.
While exploring this question, an unexpected finding, despite what existing literature 
might suggest, was that GAPDH does not appear to be a good internal control for assessing 
effects of exercise on gene expression. This became a limitation of data analysis. The most 
widely accepted methodology of analyzing real-time RT PCR is by using an internal control 
(“housekeeping gene”). Since the intended internal control, GAPDH, was significantly different 
between the groups, this methodology could not be used for analysis. Alternately, the log
CTtransformation of CT was used (2 ). Although this is not the first choice of analysis, it does
provide data on the raw mRNA levels. The input RNA volumes were standardized for cDNA 
synthesis which was then used for RT PCR. The conditioned group did indeed show higher 
expression of SLC2A4 (15-fold) based on mRNA analysis when compared to the sedentary 
group.
A benefit of the finding related to GAPDH is that it identifies the need for additional 
methodology research in SLC2A4 gene expression in response to exercise. Valid and reliable 
internal control genes for exercise-related research need to be identified for most accurate 
analysis of the data. Because physical activity has such widespread impact on physiological 
systems, this could prove challenging.
In addition to mRNA, this study attempted to assess MEF2 and HDAC5 binding to the 
SLC2A4 promoter region. Again, the goal was to determine whether transcriptional activity in
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PBMCs appeared to mimic what literature demonstrates occurs in skeletal muscle tissue. 
Chromatin was extracted using a commercial kit and then MEF2 and HDAC5 were 
immunoprecipitated using a commercial ChIP kit. There was insufficient yield at the end of this 
stage of the experiment to move forward with analyzing MEF2 and HDAC5 binding. Although 
this was an unfortunate outcome for the present study results, it does provide information about 
future methodology. Obtaining a blood cell count of samples prior to chromatin extraction would 
have allowed input into the experiment based on actual blood cell numbers as opposed to 
estimation of blood cell count based on blood volume. Additionally, a larger volume of blood 
collection would have allowed for more input material as well as an opportunity to replicate the 
experiment if  needed. Based on this study, no conclusions can be drawn regarding whether 
MEF2 and HDAC5 activity on SLC2A4 in PBMC correlate with activity in skeletal muscle 
tissue.
5.4 Sex and GLUT-4 Protein
An unexpected, yet important, finding of this study was that females had higher GLUT-4 
levels than males. Conditioning attenuated this effect to some extent. Many human studies on 
GLUT-4 upregulation in response to exercise have been conducted exclusively on male subjects. 
It may be that upregulation of GLUT-4 is more responsive to exercise in males than in females. 
There is little in the literature regarding the role of sex in GLUT-4 regulation in skeletal muscle. 
This needs to be explored both in skeletal muscle and PBMCs.
5.5 Summary of Key Findings
In summary, several key findings from this study can guide future research:
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1) GLUT-4 protein on PBMCs may respond to exercise in a similar fashion to myocyte 
GLUT-4. Muscle biopsy would be needed to validate the use of PBMCs as a proxy 
tissue for the study of skeletal muscle GLUT-4 response to exercise.
2) Diet should be accounted for in the study design of GLUT-4 regulation as it may play 
a role in transcription and/or translocation of GLUT-4.
3) SLC2A4 transcription in PBMCs may occur in a similar fashion in response to 
exercise as SLC2A4 transcription in skeletal muscle tissue. In order to accurately 
study this, an acceptable internal control gene needs to be identified.
4) Sex must be considered in studies of GLUT-4. Females demonstrate higher GLUT-4 
levels and may have less GLUT-4 response to exercise than males.
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Chapter 6: Future Directions
Although the present study was unable to provide definitive conclusions regarding the 
use of PBMCs for the study of GLUT-4 regulation, the data do suggest this warrants further 
exploration. This chapter addresses study design considerations (Table 6) to investigate the use 
of PBMC as a proxy tissue for myocytes in the study of exercise and lifestyle impacts on GLUT-
4.
6.1 Participant Selection
The literature is inconclusive as to whether GLUT-4 regulation in response to exercise 
differs between individuals with normal glucose metabolism and impaired glucose tolerance or 
diabetes. For this reason, it would be important to specify boundaries for blood glucose 
regulation in the participant selection criteria. Since the largest body of literature in humans 
addresses GLUT-4 regulation in individuals without impaired glucose tolerance that should be 
the selection criteria for an initial study. This would be consistent with the participants of the 
present study. If funding and time allowed, it would be insightful to have one group of 
participants with impaired glucose tolerance or type 2 diabetes and one group with normal 
glucose regulation.
Both chronic and acute exercise has an impact on GLUT-4 regulation in myocytes 
therefore participants with different pre-study exercise habits may introduce a confounding 
factor. It is proposed that participant selection criteria would exclude participants who engage in 
more than 20 minutes of moderate physical activity more than 3 times per week. It is
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recommended to use the IPAQ short form as a pre-screening tool to verify that participants are 
similar in their exercise habits.
Medical conditions such as thyroid disorder and pregnancy would be exclusion criteria 
due to the potential for affecting GLUT-4 regulation. Due to the key role the liver plays in 
glucose metabolism, individuals with known liver disease or dysfunction would also be 
excluded. Individuals taking corticosteroids or hypoglycemic medications would be excluded.
All prospective participants would need to be medically able to participate in the exercise portion 
of the intervention.
Based on the results of the present study that sex likely has an impact on GLUT-4 levels 
and potentially on GLUT-4 regulation, sex must be accounted for. Ideally, one-half of the 
participants would be male and one-half female. Dividing into these subgroups however reduces 
the statistical power therefore if a large enough sample size is not feasible it is recommended to 
select only one sex. Since the proposed study would be early work in this area, it is 
recommended that if  only one sex can be used that it be males since the majority of literature 
currently includes exclusively males. Subsequent studies could look to replicate the results in 
females.
6.2 Study Protocol
The study would be designed to compare PBMC GLUT-4 to myocyte GLUT-4 in an 
attempt to validate PBMC as a proxy tissue for myocytes for the study of GLUT-4. An exercise 
intervention would be provided and laboratory data collected and analyzed to assess effects of a 
single exercise bout (30 and 60 minutes) and two weeks of moderate exercise.
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Previous studies have utilized exercise at a VO2 max ranging from 60-75% with 75%
21 24 28 78 112being the most common. ’ ’ ’ ’ For the proposed study, an exercise intensity of 75% VO2 
max is suggested. The exercise could be done on a treadmill or exercise bicycle.
21Muscle biopsy would be from vastus lateralis muscle as described in previous studies.
24 28 77 78 112’ ’ ’ ’ Collection of PBMCs would be done with the same protocol as the present study 
however three 8-ml tubes would be collected instead of one to ensure adequate sample for all 
procedures and potential need for replicates.
Dietary intake could affect GLUT-4 levels, particularly if caloric intake or carbohydrate 
intake is high. Ideally, participants would be given food boxes for the duration of the study that 
provided them a modest carbohydrate diet (50-60% carbohydrate) meeting their individual 
calorie needs as determined by indirect calorimetry. If it was not possible to have that level of 
control, participants could be educated on a modest carbohydrate diet so they were not limiting 
carbohydrates nor eating excessive amounts. Participants could be asked to record their food 
intake in the ASA24 self-administered 24-hour recall system daily to assess total caloric intake 
and macronutrient distribution.
TABLE 6: Overview of Proposed Future Study Protocol
Time Frame Interventions/ Protocols Lab Tests / Procedure
Prior to initiation of study 
(1-3 weeks prior)
• None • Pre-screening 
questionnaires (medical, 
exercise)
• Fasting blood glucose and 
HbA1c to verify normal
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TABLE 6 Cont.
blood glucose levels
• VO2 max
• Resting Metabolic Rate 
via indirect calorimetry 
(Parvo Metabolic Cart)
• Height, weight, and body 
composition via BodPod
• Participant orientation and 
training on diet recording 
tool
Day 1 • 30 minutes exercise
• Exercise done at least 4 
hours after eating to 
minimize any effect of 
food on GLUT-4
• Sample schedule: 
participant eats breakfast 
at 7 AM, comes to clinic 
at 11 AM for blood draw 
and muscle biopsy, 
performs 30 minute 
cycling, returns to clinic at 
6 PM for second blood
• Muscle biopsy
• PBMC
• Collection of each done 
pre-exercise, 6 hours post 
exercise, and 18 hours 
post-exercise
58
TABLE 6 Cont.
draw and muscle biopsy, 
then returns to clinic at 
noon on following day for 
third blood draw and 
muscle biopsy.
Days 2-4 • 30 minutes exercise daily • None
Day 5 • Rest • None
Day 6 • 60 minutes exercise
• Exercise done at least 4 
hours after eating to 
minimize any effect of 
food on GLUT-4
• Sample schedule: 
participant eats breakfast 
at 7 AM, comes to clinic 
at 11 AM for blood draw 
and muscle biopsy, 
performs 60 minute 
cycling, returns to clinic at 
6:30 PM for second blood 
draw and muscle biopsy, 
draw and muscle biopsy,
• Muscle biopsy
• PBMC
• Collection of each done 
pre-exercise, 6 hours post 
exercise, and 18 hours 
post exercise
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TABLE 6 Cont.
then returns to clinic at 
12:30 on following day 
for third blood draw and 
muscle biopsy.
Days 7-9 • 60 minutes exercise daily • none
Day 10 • Rest • none
Day 11-14 • 60 minutes exercise daily • none
Day 15 • none • Muscle biopsy
• PBMC
• Collection of each done at 
24 hours following last 
exercise session
• VO2 max
6.3 Laboratory Analysis
Laboratory analysis would focus on GLUT-4 protein and SLC2A4 mRNA content in 
myocytes and PBMCs. The data would be analyzed from two primary perspectives:
1) To determine whether the quantity of GLUT-4 protein and SLC2A4 mRNA in myocytes 
correlates with the quantity in PBMC in a given individual at a given point in time.
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2) To elucidate whether the effects of exercise impact GLUT-4 protein and SLC2A4 mRNA 
in a similar fashion in myocytes and PBMCs.
6.3.1 GLUT-4 Protein
The PBMCs and myocytes would be analyzed via flow cytometry to obtain a cell count 
and cell surface GLUT-4 protein. Obtaining a cell count would allow expression of GLUT-4 per 
a particular quantity of cells. The present study used ELISA for analyzing GLUT-4 however the 
vast majority of literature has utilized flow cytometry. ELISA is attractive due to the ease of the 
procedure and ability to store cells for a longer period of time prior to analysis. For this reason, it 
is suggested that ELISA be conducted additionally so the results from flow cytometry and 
ELISA could be compared to help validate ELISA as a methodology for assessing cell surface 
GLUT-4 protein.
6.3.2 SLC2A4 mRNA
SLC2A4 mRNA would be analyzed with real time RT-PCR as was done in the methods 
of the present study however an internal control gene would be validated prior to running the 
experimental protocol. Candidate internal controls include cyclophilin, beta-actin, and 28S rRNA
24 28 77 112because of their use in similar human studies. ’ ’ ’ An internal control would be selected and 
utilized following this validation.
6.4 Conclusions
GLUT-4 regulation is a key aspect of blood glucose control. A better understanding of 
how environmental and pharmacological treatments may be able to upregulate GLUT-4 would
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be valuable. In order for human research to progress more rapidly in that area, it would be 
beneficial to have an easily obtained cell type to study. The present study suggests that PBMCs 
may be a viable cell type for this purpose. The proposed study would allow further exploration of 
this hypothesis.
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Appendix B 
Demographic and Medical Questionnaire
Demographic and Medical Screening Questionnaire
Date:_________________________ Study # ________________________
Introduction to general screening questionnaire: We would like to ask you a few general screening 
questions and some specific questions about your medical history and medications you’re currently 
taking. This will take about 10 minutes. Please leave a blank for any question you do not wish to answer 
or do not know the answer.
Please Circle One.
01. Sex:
1. M
2. F
02. Where do you currently live? On-campus housing , Off-campus , with your
parents ?
03. Who currently lives in your household and how are they related to you? (Circle ALL that 
apply)
Relationship How
Many?
Relationship How Many? Relationship How
Many?
1. Wife 8. Sister 15. Niece
2. Husband 9. Grandmother 16. Nephew
3. Daughter 10. Grandfather 17. Cousin
4. Son 11. Granddaughter 18. Girlfriend
5. Mother 12. Grandson 19. Boyfriend
6. Father 13. Aunt 99. Other
7. Brother 14. Uncle
04. What is your academic standing (freshman, sophomore etc.)?.
05. Where do you most often eat? (Please circle only one)
1. Cook for myself at home
2. Eat at campus dinning facility
3. Eat out in town
4. Eat with my family at home
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06. Do you receive assistance to pay for food (i.e., food stamps or WIC coupons)?
1. Yes
2. No
3. No Response
07. What is your race? (Circle all that apply)
1. Alaska Native
2. White
3. Black or African American
4. Asian
5. O ther_________________
08. How often do you eat Alaskan wild fish, seafood, game or berries?
1. A lot
2. Some
3. Not at all
4. No Response
09. Have you ever used any type of tobacco products?
1. Yes
0. No (Skip to question 17)
010. I have used tobacco products
1. But no longer use 
question 011)
2. Have quit some tobacco products but still use tobacco 
question 011)
3. And currently use tobacco 
question 014)
Please give answers for each type of tobacco product you used but quit: (Put a "0” in the first 
column if you never used that type of tobacco)
(i) (ii)
(iii)
Avg. number used/day Age when started use
Age when quit 
Type of tobacco used
011. Smoked cigarettes # cigs ______  _______
012. Chewed commercially-prepared # chews ______  _______
(i.e. Levi-Garrett or Redman)
013. Used Snuff # of dips ______  _______
(i.e. Copenhagan or Skoal)
(If no longer use tobacco, go to question 35)
(Go to 
(Go to 
(Go to
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Please give answers for each type of tobacco you now use: (Put a "0” in the first column if you 
never used that type of tobacco)
(i) (ii)
Avg. number use/day Age when started use
014. Smoke cigarettes #cigs ______  _______
015. Chew commercially-prepared # chews
(i.e. Levi-Garrett or Redman)
016. Use snuff # of dips
(i.e. Copenhagan or Skoal)
017. Do you consume alcohol?
1. Yes How many drinks per week
2. No
The following questions are about your medical history.
018. Are you currently taking any medications prescribed by a health care provider?
1. Yes Which ones?________________________________________________
0. No
019. Are you taking vitamins or other supplements?
1. Yes Which ones? ______________________________________________
0. No
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020. Have you or a family member related by blood (parents [p], siblings [s], children [C])
ever been diagnosed with any of the following (DO nOt  provide names of family members, only 
the number of family members):
Self Yes No Unknown Family member(s) Yes No Unknown How many of each?
1 0 8888 1 0 8888 P /  S  /  C
Arthritis □ □ □ Arthritis □ □ □ /  /
Osteo □ □ □ Osteo □ □ □ / /
Rheumatoid □ □ □ Rheumatoid □ □ □ / /
Asthma □ □ □ Asthma □ □ □ / /
Cancer □ □ □ Cancer □ □ □
/ /
Breast □ □ □ Breast □ □ □ / /
Colon □ □ □ Colon □ □ □ / /
Lung □ □ □ Lung □ □ □ / /
Ovarian □ □ □ Ovarian □ □ □
/ /
Prostate □ □ □ Prostate □ □ □
/ /
Stomach □ □ □ Stomach □ □ □
/ /
Other □ □ □ Other □ □ □ / /
Diabetes Type I □ □ □ Diabetes Type I □ □ □ / /
Diabetes Type II □ □ □ Diabetes Type II □ □ □ / /
Gestational Diabetes □ □ □ Gestational Diabetes □ □ □
/ /
Depression □ □ □ Depression □ □ □
/ /
Gall Bladder/Stones □ □ □ Gall Bladder/Stones □ □ □ / /
Heart Attack □ □ □ Heart Attack □ □ □
/ /
High Cholesterol □ □ □ High Cholesterol □ □ □ / /
Hypertension □ □ □ Hypertension □ □ □
/ /
Kidney failure □ □ □ Kidney failure □ □ □
/ /
Osteoporosis □ □ □ Osteoporosis □ □ □
/ /
Overweight □ □ □ Overweight □ □ □
/ /
Stroke □ □ □ Stroke □ □ □
/ /
Thyroid Disorder □ □ □ Thyroid Disorder □ □ □ / /
Others Others
Pacemaker □ □ □
DO NOT MEASURE BODY FAT ON TANITA IF “YES” TO PACEMAKER
Now we’d like to collect some information on your body 
measurements.
021. Height: in. (measured by researcher)
Tanita Data: Results from Impedance Analyzer
022. Weight: 
here)
lbs. (Please tape tanita printout
023. BMI:
024. Percent body fat: %
V
025. BMR: Kcal
026. Impedance: ,
027. Fat Mass: lb.
028. FFM: lb.
029. TBW: lb.
030. Height entered into Tanita:____ ft. in.
031. Waist circumference: cm 2nd Measure: 3rd Measure:
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032. Blood pressure: 1s measurement: Systolic . Diastolic Pulse
2nd measurement: Systolic . Diastolic Pulse
3rd measurement: Systolic Diastolic Pulse
Average measurement: Systolic
Data from Cholestech:
Analysis
033. Triglycerides:____________ mg/dl
here)
040. Cholestech D ate:______
041. Cholestech Time:______
042. NPO after (last eat) Date:
043. NPO after (last eat) Time:
Diastolic Pulse
Results from Blood
(Please place Cholestech printout
034. Total Cholesterol: mg/dl
V 7
035. Glucose: mg/dl
036. HDL: mg/dl
037. LDL: mg/dl
038. VLDL: mg/dl
039. HbA1c: %
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044. Blood drawn at Date:
045. Blood drawn at Time:
87
International Physical Activity Questionnaire Short Form (IPAQ-SQ)
S tu d y  # _____________
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE
We are interested in effects of physical activity on insulin signaling. The questions will 
ask you about the time you spent being physically active in the last 7 days. Please 
answer each question even if you do not consider yourself to be an active person. 
Please think about the activities you do at work, as part of your house and yard work, to 
get from place to place, and in your spare time for recreation, exercise or sport.
Think about all the vigorous activities that you did in the last 7 days. Vigorous 
physical activities refer to activities that take hard physical effort and make you breathe 
much harder than normal. Think only about those physical activities that you did for at 
least 10 minutes at a time.
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling?
 days per week
Appendix C
No vigorous physical activities ► Skip to question 3
2. How much time did you usually spend doing vigorous physical activities on one of those days?
  hours per day
  minutes per day
Don't know/Not sure
Think about all the moderate activities that you did in the last 7 days. Moderate 
activities refer to activities that take moderate physical effort and make you breathe 
somewhat harder than normal. Think only about those physical activities that you did for 
at least 10 minutes at a time.
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3. During the last 7 days, on how many days did you do moderate physical
activities like carrying light loads, bicycling at a regular pace, or doubles tennis? 
Do not include walking.
 days per week
No moderate physical activities ► Skip to question 5
4. How much time did you usually spend doing moderate physical activities on one of those days?
  hours per day
  minutes per day
  Don't know/Not sure
Think about the time you spent walking in the last 7 days. This includes at work and at 
home, walking to travel from place to place, and any other walking that you might do 
solely for recreation, sport, exercise, or leisure.
5. During the last 7 days, on how many days did you walk for at least 10 minutes 
at a time?
 days per week
No walking ► Skip to question 7
6. How much time did you usually spend walking on one of those days?
  hours per day
  minutes per day
  Don't know/Not sure
The last question is about the time you spent sitting on weekdays during the last 7 days. Include time 
spent at work, at home, while doing course work and during leisure time. This may include time spent 
sitting at a desk, visiting friends, reading, or sitting or lying down to watch television.
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7. During the last 7 days, how much time did you spend sitting on a week day?
  hours per day
  minutes per day
  Don't know/Not sure
This is the end of the questionnaire, thank you for participating.
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Appendix D 
Western Blot Optimization Trials 
Western Blotting Antibody Concentrations / Reaction Optimization
Anti-GEF / SLC2A4RG primary antibody; anti-rabbit secondary antibody
Experiment Primary Secondary Notes / Results on Imaging
1 1:1000 1:2000 Very faint, if  any, band was seen where 
would be expected for GEF at about 41 
kDa.
2 1:500 1:2000 No real improvement over experiment 1.
4 1:1000 1:2000 Very faint lines observed at about 41 kDa, 
but a significant amount of non-specific 
binding still observed on the blot.
5 1:1000 1:100,000 No visible lines seen where GEF expected 
to be
6 1:1000 1:10,000 No clear lines; continues to be significant 
background noise in the image.
Anti-GLUT4 primary antibody; anti-mouse secondary antibody
Experiment Primary Secondary Notes
1 1:500 1:2000 Bands were seen where expected for 
GLUT4 at about 54 kDa, however there
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were large amounts of other non-specific 
binding / noise.
3 1:500 1:4000 Continued to have large amounts of non­
specific binding/noise.
On experiment 1, both primary and secondary antibodies were added simultaneously. The 
membrane was then stripped and all further experiments (2-6) were conducted with one primary 
and one secondary antibody at a time.
Experiment 1 had large amounts of non-specific binding/noise and little, if  any, visible band for 
GEF. It was suspected that there was too low of a concentration of primary antibody for GEF and 
the mouse secondary antibody was too concentrated.
The membrane was stripped between each subsequent experiment.
For experiment 2, the anti-GEF antibody concentration was increased and the secondary was left 
at 1:2000. Very faint lines were observed where expected, but there continued to be large 
amounts of non-specific binding/noise in the image.
For experiment 3, the anti-GLUT4 antibody was left at a concentration of 1:500, but the 
concentration of the secondary was reduced to 1:4000. This did not appear to improve the non­
specific binding/noise in the image.
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For experiments 4-6, the anti-GEF antibody was used, with a concentration of 1:1000. The 
secondary antibody was adjusted in concentration as shown above.
93
